FDA — authorised 16 June 2013
- Application: NDA205713
- Marketing authorisation holder: AIR LIQUID INDUSTRIAL US LP
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
🇺🇸 OXYGEN in United States
FDA authorised OXYGEN on 16 June 2013 · 41,953 US adverse-event reports
Marketing authorisations
FDA — authorised 16 June 2013
- Application: NDA205712
- Marketing authorisation holder: AIR LIQUID INDUSTRIAL US LP
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 23 June 2013
- Application: NDA205737
- Marketing authorisation holder: AIR LIQUIDE LARGE INDUSTRIES US LP
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 5 July 2013
- Application: NDA205817
- Marketing authorisation holder: LINDE NORTH AMERICA INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 5 July 2013
- Application: NDA205764
- Marketing authorisation holder: LINDE NORTH AMERICA INC
- Status: approved
FDA — authorised 5 July 2013
- Application: NDA205767
- Marketing authorisation holder: LINDE NORTH AMERICA INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 5 July 2013
- Application: NDA205818
- Marketing authorisation holder: LINDE GAS PUERTO RICO INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 14 July 2013
- Application: NDA205820
- Marketing authorisation holder: NORCO INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 23 July 2013
- Application: NDA205865
- Marketing authorisation holder: AIR PRODUCTS AND CHEMICALS INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 2 August 2013
- Application: NDA205889
- Marketing authorisation holder: MATHESON TRI-GAS INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 27 August 2013
- Application: NDA205986
- Marketing authorisation holder: PRAXAIR CANADA INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 7 September 2013
- Application: NDA206023
- Marketing authorisation holder: AIRGAS USA LLC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 3 September 2017
- Application: NDA210844
- Marketing authorisation holder: PRAXAIR MEXICO
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 17 December 2017
- Application: NDA211270
- Marketing authorisation holder: LINDE GAS PUERTO RICO INC
- Indication: Medical Gas
- Status: approved
FDA — authorised 24 August 2018
- Application: NDA212314
- Marketing authorisation holder: UNIVERSAL INDUSTRIAL GASES, INC
- Status: approved
FDA — authorised 10 September 2018
- Application: NDA211739
- Marketing authorisation holder: CRISTAL ASU LLC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 2 June 2020
- Application: NDA214857
- Marketing authorisation holder: AIR LIQUIDE CANADA INC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
FDA — authorised 10 June 2022
- Application: NDA217500
- Marketing authorisation holder: ABSOLUTE AIR, LLC
- Local brand name: OXYGEN, USP
- Indication: GAS — INHALATION
- Status: approved
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 41,953
Most-reported reactions
- Dyspnoea — 9,395 reports (22.39%)
- Cough — 4,363 reports (10.4%)
- Headache — 4,314 reports (10.28%)
- Diarrhoea — 3,908 reports (9.32%)
- Fatigue — 3,872 reports (9.23%)
- Pneumonia — 3,841 reports (9.16%)
- Nausea — 3,728 reports (8.89%)
- Dizziness — 3,155 reports (7.52%)
- Oxygen Saturation Decreased — 2,855 reports (6.81%)
- Death — 2,522 reports (6.01%)
OXYGEN in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is OXYGEN approved in United States?
Yes. FDA authorised it on 16 June 2013; FDA authorised it on 16 June 2013; FDA authorised it on 23 June 2013.
Who is the marketing authorisation holder for OXYGEN in United States?
AIR LIQUID INDUSTRIAL US LP holds the US marketing authorisation.